Abstract
Methods and results
Mice that underwent transverse aortic constriction and calcineurin transgenic (Tg) mice, both models of experimental heart failure, displayed a significant increase in cardiac expression of fetal isoform CHAPb. To investigate whether increased expression of CHAPb postnatally is sufficient to induce cardiomyopathy, we generated CHAPb Tg mice under the control of the cardiac-specific αMHC promoter. CHAPb Tg mice displayed cardiac hypertrophy, interstitial fibrosis and enlargement of the left atrium at three months, which was more pronounced at the age of six months. Hypertrophy and fibrosis were confirmed by evidence of activation of the hypertrophic gene program (Nppa, Nppb, Myh7) and increased collagen expression, respectively. Connexin40 and 43 were downregulated in the left atrium, which was associated with delayed atrioventricular conduction. Tg hearts displayed both systolic and diastolic dysfunction partly caused by impaired sarcomere function evident from a reduced force generating capacity of single cardiomyocytes. This co-incided with activation of the actin signalling pathway leading to the formation of stress fibers. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
Here, we demonstrate that the fetal CHAP isoform (CHAPb) is upregulated in a mouse model of pressure overload-induced hypertrophy. Transgenic expression of fetal isoform CHAPb in the postnatal heart displayed characteristic features of heart disease, such as induction of cardiac hypertrophy, cardiac fibrosis and left atrial enlargement as well as delayed atrio-ventricular conduction, and overall contractile dysfunction. Furthermore, downstream activation of actin signaling in these transgenic mice led to the formation of stress fibers. Together the results indicate that an upregulation of the fetal isoform CHAPb is sufficient to induce cardiomyopathy.
Methods

Generation of CHAP Tg mice
Full-length cDNA of mouse CHAPb, preceded by a N-terminal FLAG and Kozak consensus sequence, was fused to the heart-specific murine α-myosin heavy chain (α-MHC) promoter. At the 3' end of CHAP a poly-A-signal of the human growth hormone (hGH) was included. Plasmid DNA was linearized by digestion with NotI, gel purified and dialyzed against Tris-EDTA (TE) buffer. DNA was injected into pronuclei from mice with a C57BL/6-CBA background. Transgenic (Tg) founder mice were crossed back (5 generations) to C57BL/6 mice to obtain a pure background. For genotyping genomic DNA was isolated from mice tail biopsies and analysed by PCR with a forward primer recognizing the C-terminus of CHAP (5'-TGGT GAAACCCCGTCTCTAC-3') and a reverse primer recognizing the hGH polyA signal (5'-C AGATTTTCCACTCCTGCAC-3'). All animal experiments were carried out in accordance with Dutch law and approved by the animal experimental committee of the Leiden University Medical Centre (permit number 09129).
Furthermore, the animal experiments were performed conform the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.
Western blot
CHAP Tg mice and wild type littermates were sacrificed by cervical dislocation. Hearts were harvested, rinsed in PBS, snap frozen in liquid nitrogen and stored at -80˚C until further use. Hearts were homogenized using an ultra-turrax tissue separator (IKA, Germany) in T-PER tissue protein extraction reagent (Pierce) supplemented with: protease inhibitor cocktail tablets (10 μg/ml; Roche, Germany), 0.1 mmol/L dithiothreitol (DTT; Invitrogen) and 1 mmol/L phenylmethanesulfonylfluoride (PMSF; Sigma Aldrich), 5 mmol/L NaF and 1 mmol/L Na 3 VO 4 ). Samples were incubated on ice for 15 minutes and centrifuged at 10.000 xg at 4˚C for 10 minutes and supernatants were transferred to new tubes. Protein concentration was determined by the Bradford assay (BioRad) using bovine serum albumin as a standard. Proteins (50μg/ lane) were separated by SDS-page gel electrophoresis and subsequently blotted using Hybond-P membranes (GE Healthcare) 3 hours at RT. Incubation with the following antibodies was performed overnight at 4˚C in 5% milk/TBS-Tween (unless stated else): CHAP 
Southern blot analysis
Genomic DNA of wild-type and CHAPb Tg mouse tails was extracted in 0.5 ml tail lysisbuffer (50 mM Tris pH 8.0, 100 mM EDTA pH 8.0, 100mM NaCl, 1% SDS and 10 mg/ml prot K) at 55 o C overnight. DNA was precipitated by phenol-chloroform extraction and 10 μg DNA was digested by BamHI (Promega) or XmnI (New England Biolabs) overnight and run on a 1% agarose gel. Probes were generated using the following primers: 5'-AGGGGTCCAGCTC TTTGAAC-3' and 5'-AGGCTTAAAGCGTCCTCCTC-3'. The PCR products were then radioactively labelled using α-[p32]dATP (PerkinElmer) by random priming (RadPrime, Invitrogen). DNA blots (Hybond-N+, GE Healthcare) were hybridized with the radioactive probe in ExpressHyb Hybridization buffer (Clontech) and visualized by using a Phosphorimager.
RNA isolation and quantitative PCR
Hearts were homogenized in TRIzol (Invitrogen) using an ultra-turrax tissue separator (IKA, Germany) and RNA was isolated according to the supplier's protocol. RNA was treated with DNase (DNA-free, Ambion) and cDNA was made with the iScript kit (BioRad). qPCR was performed using the CFX96 Real-Time PCR detection system (Bio-Rad). For details on the primers used see S1 Table. Data were analyzed with Bio-Rad CFX Manager.
Transmission Electron Microscopy (TEM)
Hearts of CHAPb Tg mice and wild type littermates were collected and left ventricles were used for TEM. For electron microscopy samples were fixed in glutaraldehyde (2.5%) in 0.1 mol/L phosphate buffer for 24 hours, post fixed in 1% OsO 4 in 0.1 mol/L cacodylate buffer for 1 hour at 4˚C, dehydrated in a graded ethanol series and embedded in an epoxy resin. Ultrathin sections were post stained with uranyl acetate and lead citrate and viewed and imaged with a FEI Tecnai 12 transmission electron microscope operated at 120 kV and equipped with an Eagle 4kx4k camera (FEI, Eindhoven, The Netherlands)
Immunohistochemistry
For histological and immunohistochemical analysis hearts were obtained at different time points (1, 3 and 6 months of age). Mice were sedated by injection of a mixture of 100 μl ketamine, 50 μl rompun and 10 μl atropine in 1ml 0.9% NaCl.
For paraffin sections mice were perfused with 0.9% NaCl and subsequently with 4% paraformaldehyde (PFA). Hearts and other organs (lungs, kidney and liver) were dissected, fixed over night in 4% PFA, dehydrated by ethanol-xylene series and embedded in paraffin. Serial heart sections (5 μm) were made, mounted on starfrost slides (Knittel) and followed by heamatoxilin-eosin (HE) staining, Sirius red staining, and immunohistochemistry as indicated. For all antibody stainings, except Myosin Light Chain 2a (MLC2a), microwave antigen retrieval in citrate buffer (pH 6) was applied. Endogenous peroxidase was blocked by incubating the slides in 0.3% H 2 O 2 in PBS. Sections were incubated overnight at room temperature with Connexin40 antibody (1:100; Santa Cruz), Connexin43 (1:500; Zymed), MLC2a (1:4000 gift from S. Kubalak) and Troponin I (TnI, 1:800; Santa Cruz). Secondary antibody used was biotinlabeled goat anti-rabbit (Vector Labs) or biotin-labeled horse anti-goat (Vector Labs). Subsequently, the sections were incubated with Vectastain ABC staining kit (Vector Labs) for 45 min. Slides were rinsed in PBS and Tris/Maleate (pH 7.6). 3-3'-diaminobenzidine tetrahydrochloride (DAB, Sigma-Aldrich Chemie) was used as chromogen and Mayer's heamatoxylin as counterstaining. Finally, slides were dehydrated and mounted with Entellan (Merck).
For cryosections mice were perfused with 0.9% NaCl only, then hearts were isolated. Processing of hearts for cryosections was adapted from Bajanca et al. [12] Serial sections (5 μm) were made and mounted on starfrost slides (Knittel) and antibody staining was performed as previously described. [13] Antibodies used were CHAP (1:50), myomesin (1:50 E. Elher), α-actinin (Sigma Aldrich), RhoA (1:100, 26C4, Santa Cruz) and pERM (1:50, Cell Signaling Technology). Secondary antibodies used are Cy-3 conjugated anti-mouse (1:250, Jackson Immunoresearch Laboratories) and Alexa488 conjugated anti-rabbit (1:200, Invitrogen). Cell nuclei were counterstained with DAPI (Molecular Probes). Stainings were analyzed with SP5 confocal microscope (Leica).
Volume measurements
The volume of the atria and ventricle was estimated by the Cavalieri principle of volume estimation. Serial sections were stained for an atrial marker, MLC2a, or cTnI to identify the ventricle. Then a grid was used to estimate the surface of the stained section and the distance between the sections was used to estimate the volume as previously described [14] .
Magnetic Resonance Imaging (MRI)
For MRI measurements 4 wild type and 5 CHAPb transgenic mice of 6 months of age were used. Animals were sedated by 4% isoflurane and MRI images were produced as described below.
All experiments were performed on a vertical 9.4T magnet (Bruker, Ettlingen, Germany) supplied with an actively shielded Micro2.5 gradient system of 1T/m and a 30 mm transmit/ receive birdcage RF coil, using Para vision 4.0 software.
MRI protocols In vivo:
At the start of each examination, several 2D FLASH scout images were recorded in the transverse and axial plane of the heart to determine the orientation of the heart.
A modified FLASH sequence with a navigator echo (IntraAngio) was used for retrospective CINE MRI with the following parameters:
Short-axis (oriented roughly perpendicular to the septum) and long-axis (oriented through the apex and aortic valve) cardiac cine MRI images with the navigator positioned through the aortic arch were acquired with the following parameters: hermite- Heart function was assessed using MASS for Mice 5.1 software package (Leiden, The Netherlands) by manual delineation of LV and RV borders.
Based on these segmented areas, LV and RV area, end-diastolic volume (EDV), end-systolic volume (ESV), LV stroke volume (SV), and LV ejection fraction were computed automatically.
Electrocardiogram (ECG) measurements
ECG measurements on wild type and CHAPb Tg mice of 6 months of age were performed as described in Henkens et al. [15] . In brief, before ECG recording, animals were anesthetized by inhalation of 4% isoflurane. Anesthesia was maintained at 2% isoflurane administration and ECG measurements were recorded for at least one minute. The data were analysed with the program LEADS and heart rate, PR duration and P duration were calculated.
Sarcomere measurements
Hearts of CHAPb Tg mice and wild type litter mates were isolated at different time points (1 month and 3 months) and snap frozen in liquid nitrogen. Single cardiomyocytes were obtained by grinding hearts in liquid nitrogen. Cardiomyocytes were defrosted in relaxing solution (pH 7.0; 1 mmol/L free Mg
mmol/L imidazole). Then cardiomyocytes were treated with relaxing solution containing 1% Triton-x-100 for 5 minutes, to remove the membranes. Cardiomyocytes were washed twice in relaxing solution to remove Triton-X-100. Single cardiomyocytes were placed between a force transducer and piezoelectric motor. Isometric force measurements were performed at 15˚C and a sarcomere length, measured in relaxing solution, of 2.2 μm. ] were obtained mixing relaxing and activation solution. The first control activation was performed at maximum [Ca 2+ ] and thereafter, the resting sarcomere length was set to 2.2 μm again. The second control measurement was performed to calculate the maximum isometric tension (force divided by cross-sectional area). The next measurements (4-5) were performed in submaximal [Ca 2+ ], followed by a control measurement. Force values obtained from submaximal [Ca 2+ ] were normalized to control values.
Protein phosphorylation
Protein phosphorylation of sarcomeric proteins was measured in hearts of CHAPb Tg and wild type litter mates at 3 months of age. Briefly, samples were separated by SDS-PAGE and gels were stained by SYPRO Ruby stain or Pro-Q Diamond Phosphoprotein Stain. A detailed description of the procedure can be found in Zaremba et al. [16] .
Statistical analysis
Data were analysed with GraphPad Prism. All data are expressed as mean + the standard error of the mean (SEM). Statistical analysis between two groups was performed using Student's unpaired t-test, or t-test with Welch's correction where appropriate (Fig 1C and 1D ). All analyses were 2-tailed and a P value less than 0.05 was considered statistically significant.
Results
CHAPb is upregulated in cardiac hypertrophy
Many genes expressed during heart development are reactivated during heart failure. Since we previously identified an important role for CHAP during cardiac development we investigated both isoforms of CHAP (S1 Fig) in an in vivo model of experimental heart failure.
Transgenic mice with cardiac-specific overexpression of a constitutively active form of calcineurin display a massive cardiac hypertrophic response [3] . In hearts of adult calcineurin Tg mice, expression of both isoforms was increased compared to expression in wild type (wt) mice at RNA ( Fig 1A) and protein level ( Fig 1B) . Next we investigated the expression of cardiac Chap in a model of pressure overload-induced hypertrophy, transverse aortic constriction (TAC). Expression of ChapA was not significantly changed at different times after TAC ( Fig  1C) , whereas ChapB was significantly increased as soon as 1 day of TAC and was maintained until three weeks of TAC, as compared to sham controls ( Fig 1D) . In summary, experimental models of cardiac hypertrophy demonstrated increased levels of both CHAP isoforms, although reactivation of fetal isoform CHAPb was predominant in the pressure overload model.
Ectopic CHAP expression in transgenic mice
In order to investigate a possible role for CHAPb in the development of cardiac hypertrophy, we generated cardiac-specific CHAPb Tg mice. These Tg mice express a N-terminal FLAGtagged CHAPb isoform in the postnatal heart under control of the cardiac-specific α-myosin heavy chain ( CHAPb expression in adult mouse heart leads to enlarged atria 
Expression of fetal isoform CHAPb in adult hearts leads to cardiac hypertrophy
We analyzed CHAPbTg mice at one, three and six months of age. At one month, hearts of wt and Tg mice were indistinguishable (S4A- S4C Fig) . At three months the left atrium of Tg hearts was enlarged without signs of thrombus formation (Fig 2A) . Tg hearts showed obvious cardiomyocyte hypertrophy with enlarged nuclei (Fig 2B) and interstitial fibrosis, indicated by Sirius Red staining (Fig 2C) . To determine the extent of cardiac hypertrophy, we measured atrial and ventricular volume at these ages. Myosin Light Chain 2a (MLC2a) and Troponin I (TnI) staining were used to identify the atria and ventricle, respectively. As expected, the volumes of the atria at one month was similar in wt and Tg mice ( By six months, left atrial enlargement was consistently more pronounced in Tg mice and was associated with cardiomyocyte hypertrophy and interstitial fibrosis (Fig 2B and 2C, S5  Fig) . Occasionally, intraventricular thrombi were identified (Fig 2E) . In general, changes in Tg hearts were more pronounced at six months, displaying features that resemble cardiomyopathy, including sudden death.
Activation of hypertrophic gene program and fibrosis in CHAPb Tg hearts
We isolated RNA from left ventricles of six-month-old wt (n = 3) and Tg (n = 3) mice to investigate gene expression. A hallmark of hypertrophy is re-expression of fetal cardiac genes, such as atrial natriuretic factor (ANF, Nppa), brain natriuretic peptide (BNP, Nppb) and β-MHC (Myh7). qPCR analysis showed significant upregulation of Nppa (17.2x, p<0.01, Fig 3A) , Nppb (3.6x, p<0.01, Fig 3B) and Myh7 (28.3x, p = 0.0634, Fig 3C) in Tg hearts. These findings corroborate the hypertrophic response observed morphologically.
Fibrosis is characterized by increased collagen production. To confirm Sirius red evidence, we analyzed the expression of Collagen I and III, the major fibrin forming collagen types. Increased expression of Collagen I (3.2x, p = 0.0506, Fig 3D) and III (3.7x, p = 0.0404, Fig 3E) was indeed observed in Tg animals, as expected. Moreover, mRNA expression of Serca2, which encodes a protein involved in Ca 2+ cycling [17] and is generally down-regulated in cardiac hypertrophy, was decreased in Tg hearts (Fig 3F) . Finally, we examined endogenous Chap isoforms in Tg mice. ChapA mRNA expression was similar in wt and CHAPb Tg hearts (Fig 3G) and although endogenous ChapB appeared slightly increased, this was not statistically significant (Fig 3I) . Exogenous ChapB (Fig 3H) was, as expected, strongly upregulated in Tg hearts compared to wt. Expression of ChapB in adult heart leads to loss of Connexins in the left atrium and conduction disturbances
Since cardiomyopathies are associated with disturbed electrical conductance and cardiac arrhythmia, we investigated the most predominant Connexin (Cx) isoforms in atria and ventricles. Cx40 is the main isoform expressed in atria. Cx43 is expressed at higher levels in ventricles and at lower levels in the atria [18] . At one month, there was no difference in Cx40 and Cx43 expression between wt and Tg (S6A and S6B Fig) . At three months, however, enlargement of the left atrium was accompanied by loss of expression of both Cx40 and Cx43, although expression in the right atrium (S6C and S6D Fig) and ventricles were unchanged. This decrease in Cx40 levels in the left atrium was more pronounced at six months (Fig 4A) . These findings were confirmed by qPCR, which showed that Cx40 (-23x, p<0.01, Fig 4B) and 43 (-6.9x, p<0.01, S5E Fig) were both downregulated in the left atrium. Similar to the protein data, mRNA expression of Cx40 and Cx43 in the right atrium was unchanged (Fig 4C and  S6F Fig) .
To investigate whether the loss of expression of Cx40 and 43 was correlated with conduction disturbances, we performed ECG measurements of wt and Tg mice. Heart rate was similar between wild type and Tg mice (S6G Fig) whereas the PR interval was increased in Tg mice (wt 40,89 ms ± 1,150 n = 3, Tg 49,83 ± 1,784 n = 8, p<0.05; Fig 4E) indicating a conduction delay from atria to ventricles. No signs of atrial fibrillation were observed, as the duration of the P-top was unchanged (wt 7,367 ms ± 0,9260 n = 3, Tg 6,955 ms ± 0,4934 n = 8, p = ns; Fig  4D) [19] .
CHAPb Tg mice show decreased cardiac performance
To determine whether the phenotypic changes in Tg hearts affected cardiac performance, we performed MRI measurements on 4 wt and 5 Tg male mice at six months. Enlargement of the left atrium was clearly visible in the scans. We then calculated the functional parameters of the Fig 5B) and end systolic volume (wt 15.72 μl ± 2.570 n = 4, Tg 7.474 μl ± 1.702 n = 5, p<0.05; Fig 5C) were significantly decreased, resulting in a similar ejection fraction in wt and Tg mice (wt 66.26% ± 3.972 n = 4, Tg 74.35% ± 5.376 n = 5, p = ns; Fig  5D) . However, the cardiac output was significantly decreased in Tg mice compared to wt (wt 1559 μl/min ± 32.20 n = 4, Tg 1083 μl/min ± 117.6 n = 5, p<0.01; Fig 5E) . Both the left ventricular mass of end diastole (wt 77.79 mg ± 2.572 n = 4, Tg 58.11 mg ± 5.399 n = 5, p<0.05; Fig  5F) and end systole (wt 93.97 ± 1.784 n = 4, Tg 71.39 ± 5.127 n = 5, p<0.01; Fig 5G) was decreased in Tg mice. Similar data were obtained for the right ventricle ( S7 Fig). Overall, these data show that CHAPb overexpression impairs diastolic and systolic function in both the left and right ventricle.
CHAPb Tg mice display decreased force generating capacity of cardiac sarcomeres
To investigate the functional properties of cardiac sarcomeres, we measured force development at different calcium concentration in membrane-permeabilized single cardiomyocytes (Fig 5H) from wt and Tg sarcomeres at one month. We observed no difference in passive force (Fig 5I) whereas at the highest calcium concentration (30 μmol/L) force development was 
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Experimental setup for single membrane-permeabilized cardiomyocyte measurements to determine sarcomere function. Sarcomere force measurements at one month of age showed no difference in passive force (I; Fpas), while maximum force (J; Fmax) and Ca 2+ -sensitivity (K; pCa 50 ) were reduced in CHAPb Tg (n = 11, black bars) compared to wt (n = 12, white bars). ED (end diastolic), ES (end systolic) and LV (left ventricular). ttest: *, p<0.05; **, p<0.01; ***, p<0.001. -sensitivity (pCa 50 , the calcium concentration at which half of the maximum force was generated) was also decreased in Tg sarcomeres compared to wt (wt 5.53 ± 0.02 n = 12, CHAPb Tg 5.45 ± 0.02 n = 11, p = 0,0046; Fig  5K) . The reduction in both maximal force and pCa 50 shows that Tg sarcomeres have less force generating capacity compared to wt sarcomeres. The phosphorylation status of the sarcomeric proteins troponin I and T, myosin binding protein C and myosin light chain 2, remained unchanged ( S8 Fig) . These results correlated with those from MRI, where we found decreased diastolic function, indicating a stiffer heart.
Sarcomeric organization is disturbed in CHAPb Tg hearts
Next we investigated the sarcomeric organization in cryosections of wt and Tg hearts. Immunohistochemical staining showed that CHAP and α-actinin-2 were co-localized at the Z-disc of wt and Tg cardiomyocytes (Fig 6A) , whereas CHAP did not overlap with myomesin (Mband protein; S9 Fig) . However, in the Tg hearts, CHAP was also localized in fibers, which appeared to be perpendicular to the sarcomeres and resembled the formation of stress fibers. These fibers stained with α-actinin (Fig 6A) , but not myomesin (S9 Fig) . These stress fibers were already visible at one month. To study the sarcomeres in more detail we performed Transmission Electron Microscopy on 6 months old wt and Tg hearts. Organization of wt sarcomeres was regular with well-formed Z-discs, M-bands and intercalated discs, whereas Tg sarcomeres were irregular and both Z-disc and intercalated discs were disorganized (Fig 6B) . Interestingly, the M-Band was not clearly visible in sarcomeres of CHAPb Tg mice.
Activation of the actin signalling pathway in CHAPb Tg hearts
Since synaptopodin, a family member of CHAP, has been associated with actin signalling in brain and kidney and since this pathway is involved in cardiac hypertrophy, we investigated the actin signalling pathway in Tg hearts. Staining of GTPase RhoA, a key component of the actin signalling pathway, in hearts of six months showed sarcomeric expression pattern in wt, while in Tg expression was increased and, interestingly, was displaced from its sarcomeric localization (Fig 6C) . To further confirm the CHAPb-dependent activation of actin signalling, we examined downstream effectors. Indeed, phosphorylation of Ezrin/radixin/moesin (ERM), a family of proteins involved in Rho-dependent signalling and linking the actin cytoskeleton to the plasma membrane [20, 21] , was increased in Tg hearts and displayed a similar localization as CHAP (S10 Fig). Increased protein expression levels of RhoA, actin, α-actinin, ERM, cofilin, and downstream actin-dependent transcription factors serum response factor (SRF) and myocyte enhancer factor-2 (MEF2) in hearts of Tg compared to wt (Fig 6D) confirmed these findings. These results suggested CHAPb dependent activation of the actin-signalling pathway, from membrane to the nucleus, which may contribute to the molecular, phenotypic and functional alterations observed in the Tg mice.
Discussion
Here we show that the Z-disc protein CHAP is upregulated in experimental models of cardiac hypertrophy and that cardiac-specific overexpression of the fetal isoform CHAPb is sufficient to induce various aspects of heart remodelling and decreased heart function. CHAP was initially identified as a gene up-regulated during the differentiation of human embryonic stem cell-derived to cardiomyocytes [7] . In mice and human two CHAP isoforms were identified which differ in their temporal expression patterns: the shorter isoform CHAPb is expressed during embryonic development in the heart, somites and muscle precursors, whilst CHAPa is Immunostaining for CHAP (green) and α-actinin (red) show stress fiber formation (white arrows) in CHAP Tg hearts (B) Electron microscopy analysis of wt and CHAPb Tg hearts at 6 months of age. In CHAPb Tg the sarcomeres were irregular and Z-discs and intercalated discs (black arrow heads) are disorganized, while Mbands are absent (white arrow heads) (C) Wt and CHAPb Tg hearts at 6 months of age stained for RhoA expressed in the adult heart and skeletal muscle. Morpholino knockdown of Chap in zebrafish showed that it is essential for heart development. Furthermore, overexpression of "embryonic" CHAPb, but not "adult" CHAPa, in rat cardiomyocytes led to dissociation of α-actinin-2 from the Z-disc [6, 22, 23] . Here we show that CHAPb Tg mice displayed features which are comparable to cardiomyopathy, such as cardiac hypertrophy, interstitial fibrosis, diastolic dysfunction, and disturbed electrical conductance, which led to higher mortality.
CHAPb induces cardiac hypertrophy, left atrial enlargement and fibrosis
CHAPb overexpression in Tg hearts was apparent both in qPCR and Western blot analysis. This had no effect at one month but by three months, molecular markers of hypertrophy were upregulated and cardiomyocyte hypertrophy without ventricular wall thickening, left atrial enlargement and interstitial fibrosis were clearly evident. This was more pronounced at six months and occasionally accompanied by wall thickening of the left and right ventricles and septum. In agreement with increasing severity of the phenotype, Tg mice died spontaneously from six months of age. Occasionally thrombi were found in the left atria, which may have disturbed blood flow in the left atrium and impaired ventricular filling. Reduced ventricular filling may eventually contribute to pulmonary venous congestion and development of pulmonary oedema. Although we did not observe pulmonary oedema overall (indicated by preserved lung weights) in Tg mice, we cannot exclude that this occurred in individual mice. Indeed, occasionally MRI, revealed white/grey areas in lungs of Tg mice, suggesting fluid retention.
Impaired structural and electrical organization at intercalated discs in CHAPb Tg hearts
In addition to the morphological and histological changes in Tg heart, we observed changes at the intercalated discs of cardiomyocytes. In particular, gap junction proteins Cx40 and Cx43 were markedly downregulated in the left atrium of Tg hearts, which was already visible at three months but more pronounced at six months of age. Since gap junctions are crucial for fast spreading of action potentials between cardiomyocytes, impaired expression of gap junctions expected to affect electrical guidance. Indeed, decreased connexins expression in the left atrium correlated with conduction disturbances, evidenced by increased PR interval, the time required for conduction between atria and ventricles. Loss of expression of Cx40 and 43 has been associated previously with conduction disturbances in mice. In Cx40 -/-mutant mice, various conduction disturbances have been reported, including increased PR interval [22, 23] . In Cx43 +/-mice ventricular conduction was delayed, [24] although no change in atrial conduction was observed [25] . In other hypertrophy mouse models, down-regulation of Cx's in the atria also correlated with conduction disturbances [26] [27] [28] . Although decreased expression of connexins and impaired electrical guidance in Tg mice was limited to the atria, detailed analysis of individual cardiomyocytes by electronmicroscopy showed that there was disorganization of Z-discs and intercalated discs throughout the whole (red). In wt mice RhoA is localized at the membrane of cardiomyocytes and shows a sarcomeric expression pattern. In CHAPb Tg hearts sarcomeric expression of RhoA is absent and membrane expression is increased. (D) Western blot analysis of 2 wt and 3 CHAPb Tg hearts at 6 months of age for RhoA (24kDa), α-actinin (100kDa), actin (42kDa), Ezrin(80 kDa)/moesin(80 kDa)/radixin (75 kDa; ERM), cofilin (19kDa), SRF (40 -67kDa) and MEF2 . GAPDH (38kDa) is used as loading control. (E) Working model: in adult wt mice CHAPa is localized at the Z-disc, leading to abundance of monomeric G-actin and subsequent low expression of SRF target genes. In CHAPb Tg mice CHAPb expression results in activation of RhoA, leading to a shift from G-actin to F-actin, binding of co-factors to SRF and activation of SRF target genes, such as ANF, BNP and β-MHC. Scale bars 20 μm in A and C, 1 μm in B.
https://doi.org/10.1371/journal.pone.0189139.g006
heart. Sarcomeric disorganization would suggest impaired contractility and/or relaxation of cardiac muscle, affecting cardiac function.
CHAPb Tg mice display cardiac diastolic dysfunction MRI measurements indicated that Tg mice had normal left ventricular ejection fraction. Similarly, in patients with heart failure, almost half (47%) still have a normal ejection fraction [29] . Ejection fraction is determined by differences in both end-diastolic and end-systolic volumes and if both parameters are changed, as occurs in Tg mice, ejection fraction may be unaffected. The decreased diastolic volumes observed in Tg mice may suggest impaired relaxation during diastole (diastolic dysfunction), which relates to impaired Ca 2+ cycling in cardiomyocytes.
Contraction of cardiomyocytes is achieved by entry of Ca 2+ through L-type channels, which causes Ca 2+ release into the cytosol, immediately followed by Ca 2+ release from the sarcoplasmic reticulum (SR). Subsequently, Ca 2+ binds to sarcomeric protein troponin C to initiate contraction. On the other hand, relaxation occurs through uptake of the Ca 2+ into the SR via SERCA2. In Tg cardiomyocytes, re-uptake of Ca 2+ might be affected, although reduced SERCA2 mRNA levels in Tg mice did not reach statistical significance [17, 30] . In addition, measurements in membrane-permeabilized cardiomyocytes revealed reduced force-generating capacity of Tg sarcomeres, which may in part underlie the significant reduction in cardiac output observed in Tg compared to wt mice. In primary cardiomyopathy, alterations in Ca 2+ -sensitivity have been reported, which may depend on the location of the mutation in affected genes. Perturbations in Ca
2+
-sensitivity of the sarcomeres may result in development of HCM or DCM [31] . As overexpression of CHAPb reduced Ca 2+ -sensitivity, it would be interesting to investigate the role of CHAP in primary cardiomyopathy cases.
Activated actin signalling in CHAPb Tg hearts
We found that expression of RhoA is increased in Tg hearts. RhoA belongs to the family of the small GTPases. Its effects on the actin cytoskeleton are mediated through stimulation of Rho Kinase (ROCK) [32] . RhoA is expressed in the heart during embryonic development, is downregulated after birth and re-expressed in cardiac hypertrophy [33] . Furthermore, RhoA Tg mice develop a phenotype that resembles DCM, which is accompanied with conduction disturbances [34] . Alternatively, inhibition of ROCK reduces pressure overload-induced hypertrophy in rats [35] . It has been previously shown that synaptopodin, is involved in actin stress fiber formation by preventing proteasomal degradation of RhoA [36] . Like synaptopodin, CHAPb might be involved in the stabilization of RhoA, which may lead to actin stress fiber formation and induction of hypertrophy via the Rho-ROCK pathway.
CHAP is involved in the SRF/MEF-2 actin signalling pathway
We observed increased expression of transcription factors SRF and MEF-2 in Tg hearts. Previously, it has been demonstrated that Striated muscle activator of Rho signalling (STARS), an actin-bundling protein localized at the Z-disc, is associated with both SRF and MEF-2 signalling. STARS is induced by MEF-2, which in turn regulates the formation of F-actin fibers via RhoA, leading to depletion of the monomeric globular actin (G-actin) pool. Consequently, a reduction of G-actin may lead to activation of SRF mediated transcription [37] [38] [39] . Previous studies in mice have indicated the relevance of SRF in the development of cardiomyopathy [40, 41] . In addition, the importance of SRF in cardiomyocyte function, maintenance and regulation was shown in experiments in which it was knocked-down: expression of cytoskeletal genes, such as α-and β-MHC, cardiac α-actin and smooth muscle actin were decreased and also, interestingly, CHAP [42, 43] . With respect to the MEF2 transcription factor family (MEF-2a, c and d), Tg mice overexpressing these genes in the heart also showed cardiac hypertrophy and stress-dependent cardiac remodelling [44] [45] [46] . The phenotypes of the different Tg models do not overlap completely with the phenotype observed here, suggesting that additional pathways may be involved in the CHAPb induced hypertrophy. In summary, our study suggests a model in which increased levels of CHAPb may activate actin signalling leading to subsequent activation of cardiac transcription factors MEF2 and SRF, initiating a hypertrophic response and structural and functional changes in cardiomyocytes (Fig 6E) .
Conclusion
We show that postnatal re-expression of the embryonic isoform of CHAP, CHAPb, is sufficient to cause cardiomyopathy with diastolic cardiac dysfunction and conduction disturbances, which is associated with sarcomere dysfunction and activation of actin signalling and of the downstream transcription factors MEF-2 and SRF. Recently, Kong et al [4] demonstrated that apart from alterations in gene expression, changes in alternative mRNAs of sarcomeric genes particularly are associated with heart failure . These findings and our study demonstrate the importance of correct dosage of sarcomeric gene isoforms and substantiate further investigation in developmentally (dys-) regulated alternative isoforms of other cardiac gene products.
Recently the genomic locus of CHAP (SYNPO2L) has been associated with AF and blood pressure regulation [9] [10] [11] 47] , which suggests that CHAP is a clinically relevant gene. The functional role of CHAP in AF and regulation of blood pressure remains elusive. It is therefore important to perform in depth functional studies of CHAP in vivo to gain insight in the molecular mechanism of disease.
Taken together, our results identify CHAPb as a novel component in the pathology of cardiomyopathy, a potential therapeutic target, and new candidate gene for screening mutations in familial cardiomyopathies and atrial fibrillation. 
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